Insights+

Insights+ Key Biosimilars Events of July 2022

Insights+ Key Biosimilars Events of July 2022

Biosimilars are developed to be highly similar versions of approved biologics in terms of safety, purity, and...

Disease of the Month: Hepatitis - D Disease | PharmaShots

Disease of the Month: Hepatitis - D Disease | PharmaShots

Hepatitis D is a liver infection caused by the Hepatitis D virus (HDV) which causes the liver to become inflamed. It...

Top Performing Drug of 2021 - Eliquis (July Edition)

Top Performing Drug of 2021 - Eliquis (July Edition)

Active Ingredients: Apixaban Strength: 2.5 mg and 5 mg ...

PharmaShots Celebrates Blooming 4 Years of Accomplishments

PharmaShots Celebrates Blooming 4 Years of Accomplishments

Shots: PharmaShots Team is pleased to announce the completion of our 4&nb...

Insights+: The US FDA New Drug Approvals in June 2022

Insights+: The US FDA New Drug Approvals in June 2022

The US FDA approved 2 NDAs and 2 BLA in June 2022, leading to treatments for patients and advances in the hea...

Insights+ Key Biosimilars Events of June 2022

Insights+ Key Biosimilars Events of June 2022

Biosimilars are developed to be highly similar versions of approved biologics in terms of safety, purity, and...

Image